Allogeneic T memory cell therapy (Instituto de Investigación Hospital Universitario La Paz)

异基因T记忆细胞疗法 (Instituto de Investigación Hospital Universitario La Paz)

Report date: 2022/07/04 19:38:02

Base Information

Drug NameAllogeneic T memory cell therapy (Instituto de Investigación Hospital Universitario La Paz)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Memory T cell therapyCell and gene therapy > Cell therapy > Donor > Allogeneic

Mechanisms of ActionT lymphocyte replacements

TargetsNot applicable

Therapy Area/IndicationsCoronavirus Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySpain

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesInstituto De Investigación Hospital Universitario La Paz

China Registration ClassN/A

Develop Information

Active CompaniesInstituto De Investigación Hospital Universitario La Paz

Inactive CompaniesN/A

Active IndicationsCoronavirus Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A